Clarivate (NYSE:CLVT) Shares Gap Down – What’s Next?

Clarivate PLC (NYSE:CLVT) gapped down prior to trading on Wednesday . The stock had previously closed at $2.40, but opened at $1.78. Clarivate shares last traded at $2.2050, with a volume of 2,699,798 shares changing hands.

Clarivate News Roundup

Here are the key news stories impacting Clarivate this week:

• Positive Sentiment: Clarivate reported second-quarter adjusted EPS of $0.19, ahead of the $0.17–$0.18 analyst consensus and up from $0.18 a year earlier. Management also reaffirmed its 2026 financial outlook and cited progress on its Value Creation Plan. Clarivate Reports Second Quarter 2026 Results
• Positive Sentiment: Stifel lowered its price target from $6.00 to $5.00 but retained a “buy” rating, implying substantial potential upside from recent trading levels. Benzinga analyst note
• Neutral Sentiment: The company is sharpening its strategic focus through the previously announced divestiture of its Life Sciences & Healthcare segment, a move intended to improve its financial profile but which also changes the business mix. Clarivate Reports Second Quarter 2026 Results
• Neutral Sentiment: Michael Easton will become Clarivate’s chief financial officer on August 8, succeeding Jonathan Collins, who is leaving to pursue another opportunity. Easton is an experienced Clarivate executive, which may support continuity, but the leadership transition adds uncertainty. Clarivate Appoints Michael Easton as Chief Financial Officer
• Negative Sentiment: Second-quarter revenue of $587.3 million fell 5.5% year over year and missed the $589.7 million consensus estimate. The revenue decline, along with Clarivate’s negative net margin, offsets some of the earnings beat. Clarivate Earnings Report
• Negative Sentiment: Citigroup and Goldman Sachs both moved to “neutral” and reduced their price targets to $2.50 and $2.60, respectively, from $2.80 and $2.90. The coordinated revisions are likely weighing on sentiment despite both targets remaining above recent levels. Benzinga analyst notes

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on CLVT. Wall Street Zen upgraded shares of Clarivate from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. Stifel Nicolaus decreased their price objective on Clarivate from $6.00 to $5.00 and set a “buy” rating for the company in a report on Thursday. The Goldman Sachs Group lowered their target price on Clarivate from $2.90 to $2.60 and set a “neutral” rating on the stock in a research report on Thursday. Weiss Ratings reiterated a “sell (e+)” rating on shares of Clarivate in a report on Wednesday, June 24th. Finally, Citigroup reduced their price target on Clarivate from $2.80 to $2.50 and set a “neutral” rating for the company in a research report on Thursday. One equities research analyst has rated the stock with a Buy rating, four have given a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Reduce” and an average price target of $3.02.

Clarivate Stock Down 6.7%

The stock has a market cap of $1.28 billion, a P/E ratio of -3.86 and a beta of 1.38. The firm has a 50-day simple moving average of $2.28 and a two-hundred day simple moving average of $2.42. The company has a current ratio of 0.84, a quick ratio of 0.84 and a debt-to-equity ratio of 0.89.

Clarivate (NYSE:CLVT) last posted its quarterly earnings data on Wednesday, July 29th. The company reported $0.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.18 by $0.01. The firm had revenue of $587.30 million during the quarter, compared to the consensus estimate of $589.73 million. Clarivate had a negative net margin of 13.84% and a positive return on equity of 9.00%. The business’s revenue for the quarter was down 5.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.18 EPS. Equities research analysts expect that Clarivate PLC will post 0.65 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the stock. Personal CFO Solutions LLC bought a new stake in Clarivate during the first quarter worth about $30,000. FreeGulliver LLC bought a new position in Clarivate in the 1st quarter valued at about $30,000. Principal Financial Group Inc. acquired a new position in shares of Clarivate in the 1st quarter valued at approximately $32,000. M&T Bank Corp acquired a new position in shares of Clarivate in the 4th quarter valued at approximately $34,000. Finally, Parallel Advisors LLC lifted its holdings in shares of Clarivate by 94.2% during the 1st quarter. Parallel Advisors LLC now owns 13,786 shares of the company’s stock worth $35,000 after acquiring an additional 6,687 shares during the period. Institutional investors own 85.72% of the company’s stock.

Clarivate Company Profile

Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.

Originally part of Thomson Reuters’ Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.